Arecor Therapeutics (AREC) Competitors GBX 62.10 +3.10 (+5.25%) As of 11:34 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock AREC vs. HVO, ORPH, REDX, ETX, FUM, SBTX, COS, TRX, C4XD, and DDDDShould you be buying Arecor Therapeutics stock or one of its competitors? The main competitors of Arecor Therapeutics include hVIVO (HVO), Open Orphan (ORPH), Redx Pharma (REDX), e-therapeutics (ETX), Futura Medical (FUM), SkinBioTherapeutics (SBTX), Collagen Solutions plc (COS.L) (COS), Tissue Regenix Group (TRX), C4X Discovery (C4XD), and 4D pharma (DDDD). These companies are all part of the "biotechnology" industry. Arecor Therapeutics vs. Its Competitors hVIVO Open Orphan Redx Pharma e-therapeutics Futura Medical SkinBioTherapeutics Collagen Solutions plc (COS.L) Tissue Regenix Group C4X Discovery 4D pharma hVIVO (LON:HVO) and Arecor Therapeutics (LON:AREC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk. Which has more risk and volatility, HVO or AREC? hVIVO has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Arecor Therapeutics has a beta of -0.18, suggesting that its share price is 118% less volatile than the S&P 500. Which has better valuation and earnings, HVO or AREC? hVIVO has higher revenue and earnings than Arecor Therapeutics. Arecor Therapeutics is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiohVIVO£68.74M1.12£17.84M£2.424.48Arecor Therapeutics£6.04M3.88-£10.68M-£28.30-2.19 Is HVO or AREC more profitable? hVIVO has a net margin of 25.96% compared to Arecor Therapeutics' net margin of -176.89%. hVIVO's return on equity of 47.93% beat Arecor Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets hVIVO25.96% 47.93% 11.97% Arecor Therapeutics -176.89%-118.67%-37.31% Do insiders & institutionals believe in HVO or AREC? 34.9% of hVIVO shares are held by institutional investors. Comparatively, 44.1% of Arecor Therapeutics shares are held by institutional investors. 14.0% of hVIVO shares are held by company insiders. Comparatively, 25.3% of Arecor Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts prefer HVO or AREC? hVIVO presently has a consensus price target of GBX 28, indicating a potential upside of 158.06%. Given hVIVO's stronger consensus rating and higher probable upside, equities analysts clearly believe hVIVO is more favorable than Arecor Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score hVIVO 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Arecor Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to HVO or AREC? In the previous week, hVIVO's average media sentiment score of 0.00 equaled Arecor Therapeutics'average media sentiment score. Company Overall Sentiment hVIVO Neutral Arecor Therapeutics Neutral SummaryhVIVO beats Arecor Therapeutics on 11 of the 14 factors compared between the two stocks. Get Arecor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AREC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AREC vs. The Competition Export to ExcelMetricArecor TherapeuticsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£23.45M£134.49M£5.45B£3.07BDividend YieldN/A3.74%3.99%5.03%P/E Ratio-2.193.7930.11170.63Price / Sales3.884,344.35379.24303,754.90Price / Cash5.0713.1935.9427.96Price / Book3.7538.648.134.52Net Income-£10.68M-£90.30M£3.26B£5.90B7 Day Performance7.07%1.91%1.15%1.25%1 Month Performance30.27%4.04%2.82%3.74%1 Year Performance-32.13%180.44%28.41%58.02% Arecor Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARECArecor TherapeuticsN/AGBX 62.10+5.3%N/A-34.4%£23.45M£6.04M-2.1910High Trading VolumeHVOhVIVON/AGBX 10-2.4%GBX 28+180.0%-65.0%£70.76M£68.74M4.12N/ANews CoverageORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179REDXRedx PharmaN/AN/AN/AN/A£58.35M£4.20M-150.00101Gap UpHigh Trading VolumeETXe-therapeuticsN/AN/AN/AN/A£52.59M£295K-450.0035High Trading VolumeFUMFutura MedicalN/AGBX 12.50+2.0%N/A-65.5%£38.96M£8.68M-10.3112News CoveragePositive NewsSBTXSkinBioTherapeuticsN/AGBX 17+1.5%N/A+24.5%£38.83M£1.56M-10.4611COSCollagen Solutions plc (COS.L)N/AN/AN/AN/A£30.99M£4.01M-8.283,350TRXTissue Regenix GroupN/AGBX 34-4.2%N/A-48.8%£30.65M£31.98M-35.10120High Trading VolumeC4XDC4X DiscoveryN/AN/AN/AN/A£30.27M£24.68M300.0049High Trading VolumeDDDD4D pharmaN/AN/AN/AN/A£30.05M£718K-1.08106 Related Companies and Tools Related Companies hVIVO Alternatives Open Orphan Alternatives Redx Pharma Alternatives e-therapeutics Alternatives Futura Medical Alternatives SkinBioTherapeutics Alternatives Collagen Solutions plc (COS.L) Alternatives Tissue Regenix Group Alternatives C4X Discovery Alternatives 4D pharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:AREC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AREC Stock Alerts